Douglas W Danielson, Age 73Minneapolis, MN

Douglas Danielson Phones & Addresses

Bloomington, MN

Rockford, MI

2713 Claridge Ct, Grandville, MI 49418 (616) 530-1864

Wyoming, MI

1594 Woodlea Dr, Otsego, MI 49078 (269) 692-2842

Saint Paul, MN

Kenton, MI

Show more

Work

Company: L. perrigo, co 1997 Position: Scientist

Education

School / High School: University of Minnesota- Minneapolis, MN 1979 Specialities: Ph.D. in Pharmaceutical Sciences

Mentions for Douglas W Danielson

Douglas Danielson resumes & CV records

Resumes

Douglas Danielson Photo 23

Douglas Danielson

Location:
Greater Minneapolis-St. Paul Area
Industry:
Graphic Design
Work:
Hefty Graphics, Inc. Jan 2002 - Nov 2009
Art Director / Group Project Leader
Offset Compositers, Inc. Jul 1976 - Jan 2002
Art Director and Department Head
Education:
Century College 1972 - 1974
AA Degree/Vocational, Graphic Communications
Skills:
Using the Adobe Creative Suite and Quark Xpress to create custom circulars, brochures, and logos, as well as supervising and training design teams, scheduling, proofing/editing, customer service, and quality control
Douglas Danielson Photo 24

Art Director

Location:
Minneapolis, MN
Industry:
Printing
Work:
Hefty Graphics
Art Director
Douglas Danielson Photo 25

Douglas Danielson

Industry:
Hospitality
Work:
Ku'uleilani Day Spa 2012 - 2015
Spa Manager
Douglas Danielson Photo 26

Douglas Danielson - Grand Rapids, MI

Work:
L. PERRIGO, CO 1997 to 2000
Scientist
SOLVAY ANIMAL HEALTH - Mendota Heights, MN 1991 to 1997
Scientist III
FORT DODGE LABORATORIES - Fort Dodge, IA 1990 to 1991
Formulation Chemist
PENNWALT CORP - Rochester, NY 1983 to 1989
Senior Research Scientist
MERRELL-DOW RESEARCH CENTER - Cincinnati, OH 1979 to 1983
Preformulation Chemist
Education:
University of Minnesota - Minneapolis, MN 1979
Ph.D. in Pharmaceutical Sciences
University of Minnesota - Minneapolis, MN 1974
B.S. in Pharmacy

Publications & IP owners

Us Patents

Microbiologically Sound And Stable Solutions Of Gamma-Hydroxybutyrate Salt For The Treatment Of Narcolepsy

US Patent:
6472431, Oct 29, 2002
Filed:
Dec 22, 1999
Appl. No.:
09/470570
Inventors:
Harry Cook - Eden Prairie MN
Martha Hamilton - St. Paul MN
Douglas Danielson - Otsego MI
Colette Goderstad - St. Paul MN
Dayton Reardan - Excelsior MN
Assignee:
Orphan Medical, Inc. - Minnetonka MN
International Classification:
A61K 3119
US Classification:
514557, 514473, 514533, 514529
Abstract:
Disclosed are formulations of gamma-hydroxybutyrate in an aqueous medium that are resistant to microbial growth. Also disclosed are formulations of gamma-hydroxybutyrate that are also resistant to the conversion into GBL. Disclosed are methods to treat sleep disorders, including narcolepsy, with these stable formulations of GHB. The present invention also provides methods to treat alcohol and opiate withdrawal, reduced levels of growth hormone, increased intracranial pressure, and physical pain in a patient.

Microbiologically Sound And Stable Solutions Of Gamma-Hydroxybutyrate Salt For The Treatment Of Narcolepsy

US Patent:
6780889, Aug 24, 2004
Filed:
Jul 11, 2002
Appl. No.:
10/194021
Inventors:
Harry Cook - Eden Prairie MN
Martha Hamilton - St. Paul MN
Douglas Danielson - Otsego MI
Colette Goderstad - St. Paul MN
Dayton Reardan - Excelsior MN
Assignee:
Orphan Medical, Inc. - Minnetonka MN
International Classification:
A61K 3119
US Classification:
514557, 514473, 514533, 514529
Abstract:
Disclosed are formulations of gamma-hydroxybutyrate in an aqueous medium that are resistant to microbial growth. Also disclosed are formulations of gamma-hydroxybutyrate that are also resistant to the conversion into GBL. Disclosed are methods to treat sleep disorders, including narcolepsy, with these stable formulations of GHB. The present invention also provides methods to treat alcohol and opiate withdrawal, reduced levels of growth hormone, increased intracranial pressure, and physical pain in a patient.

Simethicone Containing Tablet Composition And Method

US Patent:
7341742, Mar 11, 2008
Filed:
Sep 30, 2002
Appl. No.:
10/260882
Inventors:
Douglas W. Danielson - Otsego MI, US
Steven S. Schuehle - Allegan MI, US
Shirish A. Shah - Kalamazoo MI, US
Assignee:
L. Perrigo Company - Allegan MI
International Classification:
A61K 9/14
A61K 9/20
A61K 9/48
US Classification:
424464, 424451, 424452, 424465, 424489
Abstract:
A process and pharmaceutical composition containing simethicone and magnesium carbonate allows a higher production rate of simethicone containing tablets and a more consistent end product tablet. The magnesium carbonate prevents sticking of simethicone to tablet compressing apparatuses, and may also prevent sticking of other excipients to tablet compressing apparatuses.

Microbiologically Sound And Stable Solutions Of Gamma-Hydroxybutyrate Salt For The Treatment Of Narcolepsy

US Patent:
7851506, Dec 14, 2010
Filed:
Jul 13, 2007
Appl. No.:
11/777877
Inventors:
Harry Cook - Eden Prairie MN, US
Martha Hamilton - St. Paul MN, US
Douglas Danielson - Otsego MI, US
Colette Goderstad - St. Paul MN, US
Dayton Reardan - Excelsior MN, US
Assignee:
Jazz Pharmaceuticals, Inc. - Palo Alto CA
International Classification:
A61K 31/19
US Classification:
514557
Abstract:
Disclosed are formulations of gamma-hydroxybutyrate in an aqueous medium that are resistant to microbial growth. Also disclosed are formulations of gamma-hydroxybutyrate that are also resistant to the conversion into GBL. Disclosed are methods to treat sleep disorders, including narcolepsy, with these stable formulations of GHB. The present invention also provides methods to treat alcohol and opiate withdrawal, reduced levels of growth hormone, increased intracranial pressure, and physical pain in a patient.

Microbiologically Sound And Stable Solutions Of Gamma-Hydroxybutyrate Salt For The Treatment Of Narcolepsy

US Patent:
8263650, Sep 11, 2012
Filed:
Apr 13, 2012
Appl. No.:
13/446940
Inventors:
Harry Cook - Eden Prairie MN, US
Martha Hamilton - St. Paul MN, US
Douglas Danielson - Otsego MI, US
Colette Goderstad - St. Paul MN, US
Dayton T. Reardan - Shorewood MN, US
Assignee:
Jazz Pharmaceuticals, Inc. - Palo Alto CA
International Classification:
A61K 31/34
A61K 31/215
A61K 31/185
A61K 31/19
US Classification:
514473, 514529, 514553, 514557
Abstract:
Disclosed are formulations of gamma-hydroxybutyrate in an aqueous medium that are resistant to microbial growth. Also disclosed are formulations of gammahydroxybutyrate that are also resistant to the conversion into GBL. Disclosed are methods to treat sleep disorders, including narcolepsy, with these stable formulations of GHB. The present invention also provides methods to treat alcohol and opiate withdrawal, reduced levels of growth hormone, increased intracranial pressure, and physical pain in a patient.

Microbiologically Sound And Stable Solutions Of Gamma-Hydroxybutyrate Salt For The Treatment Of Narcolepsy

US Patent:
8324275, Dec 4, 2012
Filed:
Apr 13, 2012
Appl. No.:
13/446892
Inventors:
Harry Cook - Eden Prairie MN, US
Martha Hamilton - St. Paul MN, US
Douglas Danielson - Otsego MI, US
Colette Goderstad - St. Paul MN, US
Dayton T. Reardan - Shorewood MN, US
Assignee:
Jazz Pharmaceuticals, Inc. - Palo Alto CA
International Classification:
A01N 37/00
A01N 31/00
A61K 31/19
A61K 31/045
US Classification:
514557, 514724
Abstract:
Disclosed are formulations of gamma-hydroxybutyrate in an aqueous medium that are resistant to microbial growth. Also disclosed are formulations of gammahydroxybutyrate that are also resistant to the conversion into GBL. Disclosed are methods to treat sleep disorders, including narcolepsy, with these stable formulations of GHB. The present invention also provides methods to treat alcohol and opiate withdrawal, reduced levels of growth hormone, increased intracranial pressure, and physical pain in a patient.

Microbiologically Sound And Stable Solutions Of Gamma-Hydroxybutyrate Salt For The Treatment Of Narcolepsy

US Patent:
8461203, Jun 11, 2013
Filed:
Jul 13, 2011
Appl. No.:
13/182324
Inventors:
Harry Cook - Eden Prairie MN, US
Martha Hamilton - St. Paul MN, US
Douglas Danielson - Otsego MI, US
Colette Goderstad - St. Paul MN, US
Dayton T. Reardan - Shorewood MN, US
Assignee:
Jazz Pharmaceuticals, Inc. - Palo Alto CA
International Classification:
A01N 37/00
A01N 43/08
US Classification:
514557, 514473, 514529, 514553
Abstract:
Disclosed are formulations of gamma-hydroxybutyrate in an aqueous medium that are resistant to microbial growth. Also disclosed are formulations of gamma-hydroxybutyrate that are also resistant to the conversion into GBL. Disclosed are methods to treat sleep disorders, including narcolepsy, with these stable formulations of GHB. The present invention also provides methods to treat alcohol and opiate withdrawal, reduced levels of growth hormone, increased intracranial pressure, and physical pain in a patient.

Microbiologically Sound And Stable Solutions Of Gamma-Hydroxybutyrate Salt For The Treatment Of Narcolepsy

US Patent:
7262219, Aug 28, 2007
Filed:
May 7, 2004
Appl. No.:
10/841709
Inventors:
Harry Cook - Eden Prairie MN, US
Martha Hamilton - St. Paul MN, US
Douglas Danielson - Otsego MN, US
Colette Goderstad - St. Paul MN, US
Dayton Reardan - Excelsior MN, US
Assignee:
Orphan Medical, Inc. - Palo Alto CA
International Classification:
A61K 31/19
A61K 31/365
A61K 31/12
US Classification:
514557, 514553, 514473, 514529
Abstract:
Disclosed are formulations of gamma-hydroxybutyrate in an aqueous medium that are resistant to microbial growth. Also disclosed are formulations of gamma-hydroxybutyrate that are also resistant to the conversion into GBL. Disclosed are methods to treat sleep disorders, including narcolepsy, with these stable formulations of GHB. The present invention also provides methods to treat alcohol and opiate withdrawal, reduced levels of growth hormone, increased intracranial pressure, and physical pain in a patient.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.